UK-US Forge Closer Ties on Medical Device Regulations for Faster Innovations
The UK and US regulators are enhancing cooperation on medical device oversight to accelerate safe, cutting-edge technologies for patients. This expands their existing pharmaceutical partnership.
In a move aimed at streamlining access to innovative medical technologies, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) and the US Food and Drug Administration (FDA) have announced a deepening of their regulatory cooperation on medical device oversight.
This collaboration builds upon the existing pharmaceutical partnership between the two nations, as both governments seek to foster greater alignment and information-sharing to support faster, safer introduction of game-changing treatments and devices for patients.
Under the expanded framework, the agencies will work to harmonize their policies, share best practices, and align their review processes for evaluating the safety and efficacy of cutting-edge medical technologies. This includes collaborative efforts to address emerging trends, such as the growing prominence of digital health tools and combination products that blur the lines between devices, drugs, and software.
Source: UK Government
